You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 22, December 8, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Revascularization
 •Cardiovascular System
 •Women's Health
 •Pregnancy and Breast Feeding
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Anticoagulation of Pregnant Women With Mechanical Heart Valves Using Low-Molecular-Weight Heparin

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The article by Ginsberg and colleagues1 further supports the use of low-molecular-weight heparin (LMWH) in pregnant women with mechanical heart valves. In their work, the authors describe the clinical problem of anticoagulation in this situation and highlight possible management strategies with LMWH owing to superior pharmacologic properties and lower potential adverse effects compared with other therapeutic modalities.

Since Ginsberg and colleagues could only provide data of a very small number of patients with mechanical heart valve prostheses treated with LMWH, we would like to add our observations and refer to our recent report2 (Table 1) on 7 pregnant women treated with therapeutic doses of LMWH and antifactor Xa monitoring (target range antifactor Xa, 0.5.-1.2 IU/mL; blood collected 3-4 hours after injection). Besides 1 minor bleeding event in this small group of patients, this treatment regimen appeared safe and efficacious.


 
Table appears in full text version.
Patient Data


We suggest that in contrast to the . . . [Full Text of this Article]

Rupert Bauersachs, MD
Darmstadt, Germany

E. Lindhoff-Last, MD
Frankfurt, Germany



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Anticoagulation of Pregnant Women With Mechanical Heart Valves
Jeffrey S. Ginsberg, Wee Shian Chan, Shannon M. Bates, and Scott Kaatz
Arch Intern Med. 2003;163(6):694-698.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.